PatientsVille.com Logo

PatientsVille

Contraceptives Side Effects

Common Contraceptives Side Effects


The most commonly reported Contraceptives side effects (click to view or check a box to report):

Multiple Sclerosis Relapse (5)
Encephalopathy (4)
Cytotoxic Oedema (4)
Headache (3)
Dysphonia (3)
Cerebrovascular Accident (3)
Hypoaesthesia (3)
Demyelination (3)
Hemiparesis (3)
Lymphocyte Count Decreased (3)
White Blood Cell Count Decreased (3)
Visual Impairment (3)
Vaginal Haemorrhage (3)
No Adverse Event (3)
Urticaria (2)
Nausea (2)
Swelling (2)
Oedema Peripheral (2)
Oral Herpes (2)
Pain In Extremity (2)

➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

Contraceptives Side Effects Reported to FDA

The following Contraceptives reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.


The appearance of Contraceptives on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.
Injection Site Pain, Incorrect Dose Administered
This is a report of a 33-year-old female patient (weight: NA) from COUNTRY NOT SPECIFIED, suffering from the following symptoms/conditions: contraception, who was treated with Contraceptives (dosage: NA, start time: Feb 06, 2013), combined with:
  • Multivitamin
  • Humira (Loading Dose)
  • Humira
  • Asacol
  • Ativan
and developed a serious reaction and side effect(s). The consumer presented with:
  • Injection Site Pain
  • Incorrect Dose Administered
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Contraceptives treatment in female patients, resulting in injection site pain side effect.

Dyspepsia, Abdominal Pain Upper, Haematemesis
This report suggests a potential Contraceptives Nos Dyspepsia, Abdominal Pain Upper, Haematemesis side effect(s) that can have serious consequences. A 26-year-old female patient (weight: NA) from UNITED STATES was diagnosed with the following symptoms/conditions: NA and used Contraceptives Nos (dosage: NA) starting NS. Soon after starting Contraceptives Nos the patient began experiencing various side effects, including:
  • Dyspepsia
  • Abdominal Pain Upper
  • Haematemesis
Drugs used concurrently:
  • Ortho Tri-cyclen Lo
  • Aleve (2df / Oral)
Although Contraceptives Nos demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as dyspepsia, may still occur.

Pregnancy, Amniocentesis, Amniocentesis Normal
This Pregnancy, Amniocentesis, Amniocentesis Normal problem was reported by a physician from KOREA, REPUBLIC OF. A 42-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On Nov 18, 2010 this consumer started treatment with Contraceptives (dosage: NA). The following drugs were being taken at the same time:
  • Act-293987 (200 ?g, Qd)
  • Tracleer (Unk)
  • Act-293987 (400 ?g, Bid)
  • Act-293987 (200 ?g, Bid)
When commencing Contraceptives, the patient experienced the following unwanted symptoms/side effects:
  • Pregnancy
  • Amniocentesis
  • Amniocentesis Normal
Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as pregnancy, may become evident only after a product is in use by the general population.

Oral Herpes, Cytotoxic Oedema, Demyelination, Visual Impairment, White Blood Cell Count Decreased, Encephalopathy, Multiple Sclerosis Relapse, Aphasia, Dysphonia
This is a report of a 30-year-old female patient (weight: NA) from CZECH REPUBLIC. The patient developed the following symptoms/conditions: NA and was treated with Contraceptives Nos (dosage: NA) starting Mar 20, 2012. Concurrently used drugs:
  • Gilenya (0.5 Mg, Unk)
Soon after that, the consumer experienced the following side effects:
  • Oral Herpes
  • Cytotoxic Oedema
  • Demyelination
  • Visual Impairment
  • White Blood Cell Count Decreased
  • Encephalopathy
  • Multiple Sclerosis Relapse
  • Aphasia
  • Dysphonia
The patient was hospitalized. This opens a possibility that Contraceptives Nos treatment could cause the above reactions, including oral herpes, and some female subjects may be more susceptible.


Cold Sweat, Hyperventilation, Presyncope, Peripheral Coldness, Bradycardia, Pallor, Musculoskeletal Pain
A 30-year-old female patient (weight: NA) from SPAIN with the following symptoms/conditions: NA started Contraceptives treatment (dosage: NA) on May 16, 2012. Soon after starting Contraceptives treatment, the subject experienced various side effects, including:
  • Cold Sweat
  • Hyperventilation
  • Presyncope
  • Peripheral Coldness
  • Bradycardia
  • Pallor
  • Musculoskeletal Pain
Concurrently used drugs:
  • Gilenya (0.5 Mg, Qd)
This finding indicates that some female patients could be more vulnerable to Contraceptives.

Suture Rupture, Intervertebral Disc Protrusion
A 42-year-old female patient from BELGIUM (weight: NA) experienced symptoms, such as: NA and was treated with Contraceptives For Topical Use(dosage: Unk). The treatment was initiated on Nov 17, 2011. After that a consumer reported the following side effect(s):
  • Suture Rupture
  • Intervertebral Disc Protrusion
Concurrently used drugs, which potentially could have contributed to side effect(s) or affected Contraceptives For Topical Use efficacy:
  • Enbrel (50 Mg, Weekly)
The patient was hospitalized.

Vision Blurred, Hyperhidrosis, Hypertension
In this report, Contraceptives was administered for the following condition: NA.A 16-year-old female consumer from UNITED STATES (weight: NA) started Contraceptives treatment (dosage: NA) on NS.Sometime after starting the treatment, the patient complained of the following side effect(s):
  • Vision Blurred
  • Hyperhidrosis
  • Hypertension
A possible interaction with other drugs could have contributed to this reaction:
  • Strattera (40 Mg, Unk)
  • Strattera (60 Mg, Unk)
Establishing a causal relationship between a specific drug and consumer's side effects is complex, but it is possible that in this report Contraceptives treatment could be related to the listed above side effect(s).

Blood Fibrinogen Decreased, Hemianopia, White Blood Cell Count Decreased, Encephalopathy, Hemiparesis, Multiple Sclerosis Relapse, Cytotoxic Oedema, Demyelination, Lymphocyte Count Decreased
This is a report of the following Contraceptives Nos side effect(s):
  • Blood Fibrinogen Decreased
  • Hemianopia
  • White Blood Cell Count Decreased
  • Encephalopathy
  • Hemiparesis
  • Multiple Sclerosis Relapse
  • Cytotoxic Oedema
  • Demyelination
  • Lymphocyte Count Decreased
A 30-year-old female patient from CZECH REPUBLIC (weight: NA) presented with the following condition: NA and received a treatment with Contraceptives Nos (dosage: NA) starting: Mar 20, 2012.The following concurrently used drugs could have generated interactions:
  • Gilenya (0.5 Mg, Unk)
The patient was hospitalized.This report suggests that a Contraceptives Nos treatment could be associated with the listed above side effect(s).

Demyelination, White Blood Cell Count Decreased, Lymphocyte Count Decreased, Cytotoxic Oedema, Dysphonia, Visual Impairment, Encephalopathy, Multiple Sclerosis Relapse
This Contraceptives Nos report was submitted by a 30-year-old female consumer from CZECH REPUBLIC (weight: NA). The patient was diagnosed with: NA and Contraceptives Nos was administered (dosage: NA) starting: Mar 20, 2012. The consumer developed a set of symptoms:
  • Demyelination
  • White Blood Cell Count Decreased
  • Lymphocyte Count Decreased
  • Cytotoxic Oedema
  • Dysphonia
  • Visual Impairment
  • Encephalopathy
  • Multiple Sclerosis Relapse
Other drugs used simultaneously:
  • Gilenya (0.5 Mg, Unk)
The patient was hospitalized.Those unexpected symptoms could be linked to a Contraceptives Nos treatment, however establishing a potential drug-safety problem requires a more detailed clinical analysis.

Emotional Distress, Renal Vein Thrombosis, Injury, Pain, Anxiety
This is a report of a possible correlation between Contraceptives Nos use and the following symptoms/side effect(s):
  • Emotional Distress
  • Renal Vein Thrombosis
  • Injury
  • Pain
  • Anxiety
which could contribute to an assessment of Contraceptives Nos risk profile.A 17-year-old female consumer from UNITED STATES (weight: NA) was suffering from NA and was treated with Contraceptives Nos (dosage: NA) starting Jan 01, 2009.Other concurrent medications:
  • Yasmin (Unk)
  • Yaz
The patient was hospitalized.

Aphasia, Oral Herpes, Cytotoxic Oedema, Visual Impairment, Dysphonia, Encephalopathy, Multiple Sclerosis Relapse, Hemiparesis
A 30-year-old female patient from CZECH REPUBLIC (weight: NA) presented with the following symptoms: NA and after a treatment with Contraceptives Nos (dosage: NA) experienced the following side effect(s):
  • Aphasia
  • Oral Herpes
  • Cytotoxic Oedema
  • Visual Impairment
  • Dysphonia
  • Encephalopathy
  • Multiple Sclerosis Relapse
  • Hemiparesis
The treatment was started on Mar 20, 2012. Contraceptives Nos was used in combination with the following drugs:
  • Gilenya (0.5 Mg, Unk)
The patient was hospitalized.This report could alert potential Contraceptives Nos consumers.

Headache, Rash, Haematochezia, Dry Mouth
In this report, a 18-year-old female patient from UNITED STATES (weight: NA) was affected by a possible Contraceptives side effect.The patient was diagnosed with NA. After a treatment with Contraceptives (dosage: NA, start date: Mar 01, 2011), the patient experienced the following side effect(s):
  • Headache
  • Rash
  • Haematochezia
  • Dry Mouth
The following simultaneously used drugs could have led to this reaction:
  • Amnesteem
  • Amnesteem
  • Amnesteem
The findings here stress that side effects should be taken into consideration when evaluating a Contraceptives treatment.

Alopecia
This is a report of a 34-year-old female patient from UNITED STATES (weight: NA), who used Contraceptives Nos (dosage: NA) for a treatment of NA. After starting a treatment on Nov 11, 2010, the patient experienced the following side effect(s):
  • Alopecia
The following drugs could possibly have interacted with the Contraceptives Nos treatment
  • Amnesteem
Taken together, these observations suggest that a Contraceptives Nos treatment could be related to side effect(s), such as Alopecia.

Diarrhoea, Urticaria, Swelling, Nausea, Chills, Headache
This diarrhoea side effect was reported by a consumer or non-health professional from UNITED STATES. A 25-year-old female patient (weight:NA) experienced the following symptoms/conditions: contraception. The patient was prescribed Contraceptives Nos (dosage: NA), which was started on NS. Concurrently used drugs:
  • Extra Strength Tylenol
  • Benadryl
  • Benadryl
  • Tylenol-500
When starting to take Contraceptives Nos the consumer reported the following symptoms:
  • Diarrhoea
  • Urticaria
  • Swelling
  • Nausea
  • Chills
  • Headache
These side effects may potentially be related to Contraceptives Nos.

Swelling, Injection Site Pruritus, Injection Site Warmth, Injection Site Erythema
This is a Contraceptives side effect report of a 23-year-old female patient (weight:NA) from UNITED STATES, suffering from the following symptoms/conditions: NA, who was treated with Contraceptives (dosage:NA, start time: Jun 01, 2011), combined with:
  • Humira
  • Topamax
, and developed a serious reaction and a swelling side effect. The patient presented with:
  • Swelling
  • Injection Site Pruritus
  • Injection Site Warmth
  • Injection Site Erythema
which developed after the beginning of treatment. This side effect report can indicate a possible existence of increased vulnerability to Contraceptives treatment in female patients suffering from NA, resulting in swelling.

Tuberculin Test Positive
This report suggests a potential Contraceptives tuberculin test positive side effect(s) that can have serious consequences. A female patient from UNITED STATES (weight:NA) was diagnosed with the following health condition(s): contraception,psoriatic arthropathy,hypertension and used Contraceptives (dosage: Pills) starting May 01, 2011. Soon after starting Contraceptives the patient began experiencing various side effects, including:
  • Tuberculin Test Positive
Drugs used concurrently:
  • Humira
  • Benicar
  • Humira
Although Contraceptives demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as tuberculin test positive, may still occur.

No Adverse Event
This no adverse event problem was reported by a consumer or non-health professional from UNITED STATES. A 28-year-old female patient (weight: NA) was diagnosed with the following medical condition(s): NA.On NS a consumer started treatment with Contraceptives Nos (dosage: NA). The following drugs/medications were being taken at the same time:
  • Aleve (caplet)
When commencing Contraceptives Nos, the patient experienced the following unwanted symptoms /side effects:
  • No Adverse Event
Although all drugs are carefully tested before they are licensed for use, they carry potential side effect risks. Some side effects, such as no adverse event, may become evident only after a product is in use by the general population.

Hypoaesthesia, Cerebrovascular Accident
This is a Contraceptives side effect report of a 29-year-old female patient (weight: NA) from IRELAND. The patient developed the following symptoms/conditions: NA and was treated with Contraceptives (dosage: NA) starting NS. Concurrently used drugs:
  • Pradaxa
Soon after that, the consumer experienced the following of symptoms:
  • Hypoaesthesia
  • Cerebrovascular Accident
The patient was hospitalized and became disabled. This opens a possibility that Contraceptives could cause hypoaesthesia and that some female patients may be more susceptible.

Vaginal Haemorrhage
A 25-year-old female patient (weight: NA) from UNITED KINGDOM with the following symptoms: NA started Contraceptives Nos treatment (dosage: NA) on Dec 22, 2011. Soon after starting Contraceptives Nos treatment, the consumer experienced several side effects, including:
  • Vaginal Haemorrhage
. Concurrently used drugs:
  • Clotrimazole (Unk)
This finding indicates that some patients can be more vulnerable to developing Contraceptives Nos side effects, such as vaginal haemorrhage.

Sinus Tachycardia, Diarrhoea, Heart Rate Increased, Supraventricular Tachycardia, Lymphocyte Count Decreased, Neutrophil Count Increased, Chest Discomfort, Dyspnoea, Chest Pain
This sinus tachycardia side effect was reported by a health professional from UNITED STATES. A female patient (weight:NA) experienced the following symptoms/conditions: NA.The patient was prescribed Contraceptives (dosage: Unk Ukn, Unk), which was started on Dec 31, 2010. Concurrently used drugs:
  • Gilenya (0.5 Mg, Daily)
  • Levetiracetam
  • Nortriptyline Hcl (125 Mg, Unk)
  • Vitamin D (50 Kiu, Weekly)
  • Keppra (500 Mg, Bid)
  • Nuvigil (150 Mg, Daily)
.When starting to take Contraceptives the consumer reported symptoms, such as:
  • Sinus Tachycardia
  • Diarrhoea
  • Heart Rate Increased
  • Supraventricular Tachycardia
  • Lymphocyte Count Decreased
  • Neutrophil Count Increased
  • Chest Discomfort
  • Dyspnoea
  • Chest Pain
These side effects may potentially be related to Contraceptives. The patient was hospitalized.

Cholecystectomy, Cholecystitis Chronic
This is a report of a 30-year-old female patient (weight: NA) from UNITED STATES, suffering from the following symptoms/conditions: premenstrual syndrome, who was treated with Contraceptives Nos (dosage: Unk, start time: Jan 01, 2007), combined with:
  • Multi-vitamin
  • Imitrex (Unk)
  • Atenolol (25 Mg, Daily)
  • Zoloft (50 Mg, Daily)
  • Nsaid's
  • Yaz (Unk)
  • Yaz
  • Yasmin (Unk)
and developed a serious reaction and side effect(s). The consumer presented with:
  • Cholecystectomy
  • Cholecystitis Chronic
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Contraceptives Nos treatment in female patients, resulting in cholecystectomy side effect.

Procedural Pain
This report suggests a potential Contraceptives Nos Procedural Pain side effect(s) that can have serious consequences. A 18-year-old female patient (weight: NA) from UNITED STATES was diagnosed with the following symptoms/conditions: NA and used Contraceptives Nos (dosage: NA) starting Oct 12, 2011. Soon after starting Contraceptives Nos the patient began experiencing various side effects, including:
  • Procedural Pain
Drugs used concurrently:
  • Mirena (20 Mcg/24hr, Cont)
Although Contraceptives Nos demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as procedural pain, may still occur.

Cerebrovascular Accident, Hypoaesthesia
This Cerebrovascular Accident, Hypoaesthesia problem was reported by a pharmacist from IRELAND. A 29-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On NS this consumer started treatment with Contraceptives (dosage: NA). The following drugs were being taken at the same time:
  • Pradaxa
When commencing Contraceptives, the patient experienced the following unwanted symptoms/side effects:
  • Cerebrovascular Accident
  • Hypoaesthesia
The patient was hospitalized and became disabled.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as cerebrovascular accident, may become evident only after a product is in use by the general population.

Multiple Sclerosis Relapse, Cognitive Disorder, Hemiparesis, Headache, Aggression, Brain Oedema, Dehydration, Influenza, Convulsion
This is a report of a 31-year-old female patient (weight: NA) from UNITED STATES. The patient developed the following symptoms/conditions: NA and was treated with Contraceptives Nos (no Ingredients/substances) (dosage: NA) starting Dec 27, 2010. Concurrently used drugs:
  • Lexapro (escitalopram Oxalate), 5 Mg
  • Trazodone (trazodone), 50 Mg
  • Gilenya (Unk Ukn, Unk, Oral)
Soon after that, the consumer experienced the following side effects:
  • Multiple Sclerosis Relapse
  • Cognitive Disorder
  • Hemiparesis
  • Headache
  • Aggression
  • Brain Oedema
  • Dehydration
  • Influenza
  • Convulsion
The patient was hospitalized. This opens a possibility that Contraceptives Nos (no Ingredients/substances) treatment could cause the above reactions, including multiple sclerosis relapse, and some female subjects may be more susceptible.

Cerebrovascular Accident, Hypoaesthesia
A 29-year-old female patient (weight: NA) from IRELAND with the following symptoms/conditions: NA started Contraceptives treatment (dosage: NA) on NS. Soon after starting Contraceptives treatment, the subject experienced various side effects, including:
  • Cerebrovascular Accident
  • Hypoaesthesia
Concurrently used drugs:
  • Pradaxa
The patient was hospitalized and became disabled. This finding indicates that some female patients could be more vulnerable to Contraceptives.

1 of 2 



Top 10 Contraceptives Side Effects for Men

Men Side EffectsReports

Keep Track of Side Effects

Note Your Observations

It is really important to keep of your symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

Why Your Notes are Important

Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:
    Side Effects Scale Date & Time Other Medicine(s) or Treatment(s)
    Scale: 1 = very mild to 10 = very bad

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


    Discuss Contraceptives Side Effects

    Did You Have a Contraceptives Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Contraceptives for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective

    Contraceptives Safety Alerts, Active Ingredients, Usage Information

    More About Contraceptives

    Side Effects reported to FDA: 46

    Contraceptives safety alerts: 2011

    Reported hospitalizations: 8

    Qualitest Pharmaceuticals Oral Contraceptives: Recall - Packaging Error

    includes Cyclafem 7/7/7, Cyclafem 1/35, Emoquette, Gildess FE 1.5/30, Gildess FE 1/20,  Orsythia, Previfem, Tri-Previfem

     

    [Posted 09/16/2011]

    AUDIENCE: Consumer, Pharmacy, OB/GYN

    ISSUE: Qualitest Pharmaceuticals issued a nationwide, retail-level recall of multiple lots of oral contraceptives because a packaging error may result in the daily regimen for these products being  incorrect and could leave women without adequate contraception, and at risk for unintended pregnancy. Select blisters were rotated 180 degrees within the card, reversing the weekly tablet orientation and making the lot number and expiry date no longer visible.

    BACKGROUND: These packaging defects do not pose any immediate health risks. Pharmacies are being instructed to contact consumers who have received affected product.

    RECOMMENDATION: Consumers exposed to affected packaging should begin using a non-hormonal form of contraception immediately and consult their health care provider or pharmacist. Consumers who have affected products should contact Qualitest for information or to arrange return of any affected product.

    Healthcare professionals and patients are encouraged to report adverse events or side effects related to the use of these products to the FDA's MedWatch Safety Information and Adverse Event Reporting Program:

    • Complete and submit the report Online: www.fda.gov/MedWatch/report.htm
    • Download form or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178


    [09/15/2011 - Press Release - Qualitest Pharmaceuticals]

    Latest Contraceptives clinical trials